NCT03431480View on ClinicalTrials.gov

Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 16, 2018

Primary Completion Date

November 1, 2021

Study Completion Date

June 30, 2022

Conditions
Hypoplastic Left Heart SyndromeHeart Defects, CongenitalPediatric Disorder
Interventions
BIOLOGICAL

Autologous Human Placental Cord Blood Mononuclear Cells

Autologous human placental cord blood mononuclear cells are infused into the coronary artery during the Norwood heart operation

Trial Locations (1)

3052

Royal Children's Hospital, Melbourne

Sponsors
All Listed Sponsors
lead

Murdoch Childrens Research Institute

OTHER